Naldemedine is associated with earlier defecation in critically ill patients with opioid-induced constipation: A retrospective, single-center cohort study
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0295952 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Seiya Nishiyama und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care Medicine, Jichi Medical University, Saitama Medical Center, Omiya, Saitama, Japan. Hauptthemen laut MEDLINE: Analgesics, Opioid, Opioid-Induced Constipation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
There are few reports describing the association of naldemedine with defecation in critically ill patients with opioid-induced constipation. The purpose of this study was to determine whether naldemedine is associated with earlier defecation in critically ill patients with opioid-induced constipation.
Methods
In this retrospective cohort study, patients admitted to the Intensive Care Unit (ICU) without defecation for 48 hours while receiving opioids were eligible for enrollment. The primary endpoint was the time of the first defecation within 96 hours after inclusion. Secondary endpoints included presence of diarrhea, duration of mechanical ventilation, ICU length of stay, ICU mortality, and in-hospital mortality. The Cox proportional hazard regression analysis with time-dependent covariates was used to evaluate the association naldemedine with earlier defecation.
Results
A total of 875 patients were enrolled and were divided into 63 patients treated with naldemedine and 812 patients not treated. Defecation was observed in 58.7% of the naldemedine group and 48.8% of the no-naldemedine group during the study (p = 0.150). The naldemedine group had statistically significantly prolonged duration of mechanical ventilation (8.7 days vs 5.5 days, p < 0.001) and ICU length of stay (11.8 days vs 9.2 days, p = 0.001) compared to the no-naldemedine group. However, the administration of naldemedine was significantly associated with earlier defecation [hazard ratio:2.53; 95% confidence interval: 1.71–3.75, p < 0.001].
Conclusion
The present study shows that naldemedine is associated with earlier defecation in critically ill patients with opioid-induced constipation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Critical Care Medicine, Jichi Medical University, Saitama Medical Center, Omiya, Saitama, Japan.
- Data Science Center, Jichi Medical University, Shimotsuke, Tochigi, Japan.
- Department of Surgery, Jichi Medical University, Shimotsuke, Tochigi, Japan.
ORCID-Profile: Tomoyuki Masuyama, Alan Kawarai Lefor, Masamitsu Sanui
Zitieren
APA
Nishiyama, S., Uchino, S., Sasabuchi, Y., Masuyama, T., Lefor, A. K., & Sanui, M. (2024). Naldemedine is associated with earlier defecation in critically ill patients with opioid-induced constipation: A retrospective, single-center cohort study. PLOS ONE. https://doi.org/10.1371/journal.pone.0295952
Vancouver
Nishiyama S, Uchino S, Sasabuchi Y, Masuyama T, Lefor AK, Sanui M. Naldemedine is associated with earlier defecation in critically ill patients with opioid-induced constipation: A retrospective, single-center cohort study. PLOS ONE. 2024. doi:10.1371/journal.pone.0295952
BibTeX
@article{Nishiyama2024,
author = {Nishiyama, Seiya and Uchino, Shigehiko and Sasabuchi, Yusuke and Masuyama, Tomoyuki and Lefor, Alan Kawarai and Sanui, Masamitsu},
title = {Naldemedine is associated with earlier defecation in critically ill patients with opioid-induced constipation: A retrospective, single-center cohort study},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0295952}
}
EUVIMED